These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3075015)

  • 41. Hypothalamic opioid mechanisms in experimental uremic hypogonadism.
    Dong QH; Handelsman DJ
    Endocrinology; 1990 Mar; 126(3):1498-503. PubMed ID: 2137774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
    Gindoff PR; Ferin M
    Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH.
    Kalra PS; Fuentes M; Sahu A; Kalra SP
    Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disinhibition from opioid influence augments hypothalamic neuropeptide Y (NPY) gene expression and pituitary luteinizing hormone release: effects of NPY messenger ribonucleic acid antisense oligodeoxynucleotides.
    Xu B; Sahu A; Kalra PS; Crowley WR; Kalra SP
    Endocrinology; 1996 Jan; 137(1):78-84. PubMed ID: 8536645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of hypothalamic gonadotropin-releasing hormone release by endogenous opioid peptides in the female rabbit.
    Orstead KM; Spies HG
    Neuroendocrinology; 1987 Jun; 46(1):14-23. PubMed ID: 3112599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of endogenous opioid peptides in mediating progesterone-induced disruption of the activation and transmission stages of the GnRH surge induction process.
    Richter TA; Spackman DS; Robinson JE; Dye S; Harris TG; Skinner DC; Evans NP
    Endocrinology; 2001 Dec; 142(12):5212-9. PubMed ID: 11713217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in pulsatile release of neuropeptide-Y and luteinizing hormone (LH)-releasing hormone during the progesterone-induced LH surge in rhesus monkeys.
    Woller MJ; Terasawa E
    Endocrinology; 1994 Oct; 135(4):1679-86. PubMed ID: 7925132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide.
    Sahu A; Xu B; Kalra SP
    Endocrinology; 1994 Feb; 134(2):529-36. PubMed ID: 7507825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
    Gilbeau PM; Almirez RG; Holaday JW; Smith CG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endogenous opiates regulate the nocturnal reduction in luteinizing hormone pulse frequency during the luteal phase of the macaque menstrual cycle.
    Ji WZ; Kaynard AH; Pau KY; Hess DL; Baughman WL; Spies HG
    Biol Reprod; 1989 Dec; 41(6):1024-33. PubMed ID: 2624863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man.
    Veldhuis JD; Rogol AD; Samojlik E; Ertel NH
    J Clin Invest; 1984 Jul; 74(1):47-55. PubMed ID: 6429197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of season and stage of gestation on luteinizing hormone release in gilts.
    Smith CA; Almond GW
    Can J Vet Res; 1991 Jul; 55(3):294-7. PubMed ID: 1889040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of pulsatile luteinizing hormone secretion by ovarian steroids in the rat.
    Goodman RL; Daniel K
    Biol Reprod; 1985 Mar; 32(2):217-25. PubMed ID: 3986263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous opioids participate in the regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone.
    Cicero TJ; Schainker BA; Meyer ER
    Endocrinology; 1979 May; 104(5):1286-91. PubMed ID: 374068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ovarian steroids directly alter luteinizing hormone (LH) release by pituitary homografts.
    McLean BK; Chang N; Nikitovitch-Winer MB
    Endocrinology; 1975 Jul; 97(1):196-201. PubMed ID: 1095356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogenic feminization of the LH response to orchidectomy: association with prolonged nuclear estradiol receptor retention and induction of cytoplasmic progestin receptors in brain and pituitary.
    Tesone M; Negro-Vilar A
    J Steroid Biochem; 1986 Jan; 24(1):455-60. PubMed ID: 3702429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Graded hyperprolactinemia first suppresses LH pulse frequency and then pulse amplitude in castrated male rats.
    Park SK; Keenan MW; Selmanoff M
    Neuroendocrinology; 1993 Oct; 58(4):448-53. PubMed ID: 8284029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.